| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.766 | 0.003 | 0.8 | 5 Hydroxytryptamine uptake inhibitor | 0.786 0.003 CID_162180 0.8 0.003 CID_10068142 | CID_10068142 | |
| 0.711 | 0.005 | 0.722 | HERG channel blocker | 0.622 0.007 CID_162180 0.722 0.005 CID_10068142 | CID_10068142 | |
| 0.692 | 0.005 | 0.694 | Potassium channel (Voltage-sensitive) blocker | 0.618 0.006 CID_162180 0.694 0.005 CID_10068142 | CID_10068142 | |
| 0.583 | 0.006 | 0.583 | Potassium channel blocker | 0.504 0.01 CID_162180 0.537 0.009 CID_10068142 | ||
| 0.501 | 0.004 | 0.501 | Histamine H1 receptor antagonist | 0.362 0.005 CID_162180 0.158 0.022 CID_10068142 | ||
| 0.436 | 0.053 | 0.436 | Antiobesity | 0.404 0.064 CID_162180 0.258 0.149 CID_10068142 | ||
| 0.359 | 0.031 | 0.359 | Vasodilator | 0.323 0.041 CID_162180 0.18 0.122 CID_10068142 | ||
| 0.324 | 0.003 | 0.324 | Glycine transporter inhibitor | 0.262 0.003 CID_162180 0.108 0.01 CID_10068142 | ||
| 0.319 | 0.009 | 0.319 | Histamine antagonist | 0.247 0.014 CID_162180 | ||
| 0.315 | 0.009 | 0.315 | Antihistaminic | 0.246 0.014 CID_162180 | ||
| 0.309 | 0.035 | 0.309 | Ca(v)3.3 blocker | 0.277 0.065 CID_162180 0.206 0.179 CID_10068142 | ||
| 0.282 | 0.012 | 0.282 | Butyrylcholinesterase inhibitor | 0.197 0.022 CID_162180 0.113 0.051 CID_10068142 | ||
| 0.253 | 0.003 | 0.253 | Glycine transporter 1 inhibitor | 0.206 0.004 CID_162180 0.153 0.004 CID_10068142 | ||
| 0.242 | 0.005 | 0.242 | Dopamine uptake inhibitor | 0.224 0.005 CID_162180 0.057 0.041 CID_10068142 | ||
| 0.212 | 0.005 | 0.381 | Adrenaline uptake inhibitor | 0.316 0.004 CID_162180 0.381 0.004 CID_10068142 | CID_10068142 | |
| 0.236 | 0.046 | 0.236 | P-glycoprotein inhibitor | 0.214 0.056 CID_162180 0.142 0.129 CID_10068142 | ||
| 0.181 | 0.005 | 0.181 | Progesterone antagonist | 0.168 0.005 CID_162180 0.096 0.009 CID_10068142 | ||
| 0.156 | 0.014 | 0.165 | Alpha 1d adrenoreceptor antagonist | 0.165 0.013 CID_162180 | CID_162180 | |
| 0.19 | 0.047 | 0.19 | Acetylcholine M1 receptor antagonist | 0.148 0.076 CID_162180 | ||
| 0.174 | 0.032 | 0.174 | 5 Hydroxytryptamine 2B antagonist | 0.129 0.052 CID_162180 | ||
| 0.174 | 0.038 | 0.174 | DNA polymerase I inhibitor | 0.165 0.041 CID_162180 0.129 0.062 CID_10068142 | ||
| 0.174 | 0.042 | 0.174 | Acetylcholinesterase inhibitor | 0.131 0.069 CID_162180 | ||
| 0.147 | 0.023 | 0.162 | Alpha 1b adrenoreceptor antagonist | 0.162 0.02 CID_162180 | CID_162180 | |
| 0.161 | 0.045 | 0.161 | 5 Hydroxytryptamine antagonist | 0.131 0.059 CID_162180 | ||
| 0.156 | 0.042 | 0.156 | 5 Hydroxytryptamine 2 antagonist | 0.137 0.05 CID_162180 | ||
| 0.134 | 0.033 | 0.134 | Alpha 1 adrenoreceptor antagonist | 0.126 0.035 CID_162180 | ||
| 0.253 | 0.162 | 0.253 | 15-Lipoxygenase inhibitor | 0.246 0.168 CID_162180 | ||
| 0.119 | 0.031 | 0.119 | Lanosterol 14 alpha demethylase inhibitor | 0.108 0.044 CID_162180 | ||
| 0.107 | 0.019 | 0.107 | 5 Hydroxytryptamine 1 agonist | 0.098 0.021 CID_162180 | ||
| 0.151 | 0.076 | 0.151 | Cholinergic | |||
| 0.111 | 0.041 | 0.111 | Calcium antagonist | |||
| 0.081 | 0.012 | 0.081 | Potassium channel (Inward rectifier) blocker | 0.067 0.019 CID_162180 | ||
| 0.101 | 0.036 | 0.101 | Alpha 1a adrenoreceptor antagonist | 0.101 0.036 CID_162180 | ||
| 0.125 | 0.062 | 0.125 | Acetylcholine muscarinic antagonist | |||
| 0.065 | 0.004 | 0.065 | Urotensin II agonist | 0.039 0.01 CID_162180 0.028 0.017 CID_10068142 | ||
| 0.078 | 0.018 | 0.099 | Dopamine transporter inhibitor | 0.096 0.013 CID_162180 0.099 0.012 CID_10068142 | CID_10068142 | |
| 0.102 | 0.044 | 0.102 | 5 Hydroxytryptamine 2C antagonist | 0.09 0.053 CID_162180 | ||
| 0.108 | 0.052 | 0.108 | Alpha adrenoreceptor antagonist | 0.103 0.055 CID_162180 | ||
| 0.101 | 0.047 | 0.101 | Antineoplastic alkaloid | |||
| 0.073 | 0.018 | 0.073 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.059 0.023 CID_162180 0.041 0.039 CID_10068142 | ||
| 0.071 | 0.019 | 0.071 | Histamine H3 receptor antagonist | 0.051 0.026 CID_162180 | ||
| 0.072 | 0.019 | 0.072 | Neurokinin antagonist | 0.046 0.04 CID_162180 0.049 0.035 CID_10068142 | ||
| 0.064 | 0.017 | 0.064 | Mineralocorticoid receptor antagonist | 0.064 0.017 CID_162180 0.056 0.023 CID_10068142 | ||
| 0.086 | 0.039 | 0.086 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.059 | 0.015 | 0.059 | Neurokinin 1 antagonist | 0.038 0.032 CID_162180 0.045 0.023 CID_10068142 | ||
| 0.069 | 0.028 | 0.069 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.091 | 0.052 | 0.091 | 5 Hydroxytryptamine 2A antagonist | 0.071 0.066 CID_162180 | ||
| 0.052 | 0.015 | 0.052 | Substance P antagonist | 0.046 0.02 CID_10068142 | ||
| 0.11 | 0.074 | 0.11 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.145 | 0.11 | 0.145 | ATPase inhibitor | 0.137 0.126 CID_162180 | ||
| 0.176 | 0.144 | 0.176 | Cardiotonic | |||
| 0.166 | 0.141 | 0.166 | ErbB-1 antagonist | 0.16 0.155 CID_162180 | ||
| 0.035 | 0.011 | 0.035 | Potassium channel (Inward rectifier) 1 blocker | 0.032 0.016 CID_162180 0.03 0.022 CID_10068142 | ||
| 0.168 | 0.144 | 0.169 | 5 Hydroxytryptamine 3E antagonist | 0.169 0.139 CID_162180 | CID_162180 | |
| 0.072 | 0.049 | 0.072 | Calcium channel L-type blocker | |||
| 0.196 | 0.173 | 0.233 | Transcription factor NF kappa B inhibitor | 0.233 0.14 CID_162180 | CID_162180 | |
| 0.036 | 0.016 | 0.036 | Estrogen-related receptor beta antagonist | |||
| 0.088 | 0.068 | 0.088 | MAO B inhibitor | |||
| 0.073 | 0.056 | 0.089 | Vanilloid 4 agonist | 0.089 0.027 CID_162180 | CID_162180 | |
| 0.102 | 0.087 | 0.109 | Beta amyloid protein antagonist | 0.109 0.079 CID_162180 | CID_162180 | |
| 0.038 | 0.023 | 0.046 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.046 0.014 CID_10068142 | CID_10068142 | |
| 0.055 | 0.046 | 0.055 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.06 | 0.055 | 0.065 | 5 Hydroxytryptamine agonist | 0.065 0.051 CID_162180 | CID_162180 | |
| 0.056 | 0.054 | 0.056 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.036 | 0.035 | 0.036 | Neurokinin 2 antagonist | |||
| 0.082 | 0.088 | 0.12 | Topoisomerase I inhibitor | 0.12 0.056 CID_10068142 | CID_10068142 | |
| 0.03 | 0.038 | 0.16 | Kinesin-like protein 1 inhibitor | 0.16 0.005 CID_10068142 | CID_10068142 | |
| 0.03 | 0.038 | 0.16 | Kinesin antagonist | 0.16 0.005 CID_10068142 | CID_10068142 | |
| 0.061 | 0.069 | 0.064 | Secretase beta inhibitor | 0.064 0.063 CID_162180 | CID_162180 | |
| 0.088 | 0.11 | 0.103 | Nav1.5 sodium channel blocker | 0.103 0.079 CID_162180 | CID_162180 | |
| 0.074 | 0.097 | 0.123 | DNA directed RNA polymerase inhibitor | 0.123 0.035 CID_10068142 | CID_10068142 | |
| 0.037 | 0.068 | 0.046 | Parathyroid hormone antagonist | 0.046 0.03 CID_162180 | CID_162180 | |
| 0.065 | 0.102 | 0.079 | Histamine H2 receptor antagonist | 0.079 0.067 CID_162180 | CID_162180 | |
| 0.068 | 0.13 | 0.101 | Nitric-oxide synthase inhibitor | 0.101 0.059 CID_162180 | CID_162180 | |
| 0.066 | 0.133 | 0.514 | DNA intercalator | 0.514 0.005 CID_10068142 | CID_10068142 | |
| 0.062 | 0.203 | 0.103 | Glutamate (mGluR7) agonist | 0.103 0.055 CID_162180 | CID_162180 | |
| 0.153 | 0.306 | 0.252 | Analgesic | 0.252 0.181 CID_162180 | CID_162180 | |
| 0.018 | 0.234 | 0.042 | ATM kinase inhibitor | 0.042 0.014 CID_10068142 | CID_10068142 | |
| 0.008 | 0.454 | 0.06 | Check point kinase 1 inhibitor | 0.06 0.059 CID_10068142 | CID_10068142 | |
| 0.063 | 0.857 | 0.37 | Calcium channel L-type activator | 0.37 0.103 CID_162180 | CID_162180 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |